LAB EBITDA Growth
Standard Biotools Inc · EBITDA Growth
LAB EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-72.48%period ending
LAB Quarterly EBITDA YoY % (32.61% → -72.48%)
Year-over-year change
High-resolution chart · PNG
LAB ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| -72.482% | |
| 31.6266% | |
| 20.3174% | |
| -53.4687% | |
| 21.3523% | |
| 25.1376% | |
| -74.2467% | |
| -51.1611% | |
| -79.0498% | |
| -119.0137% | |
| 6.4637% | |
| 46.9476% | |
| 80.8215% | |
| 83.6059% | |
| -201.9289% | |
| -144.4892% | |
| -368.3638% | |
| -358.0635% | |
| 56.4487% | |
| -1,112.2093% | |
| -60.0124% | |
| -34.0855% | |
| -56.3281% | |
| 91.1139% | |
| 23.0254% | |
| 37.5367% | |
| -15.9773% | |
| 8.7239% | |
| -18.9636% | |
| -141.4411% | |
| -47.804% | |
| 0.8231% | |
| 22.7589% | |
| 39.2768% | |
| 67.0975% | |
| 24.2686% | |
| 17.0655% | |
| 13.8387% | |
| -34.0243% | |
| -80.9176% | |
| -39.7146% | |
| -5.9067% | |
| -11.1652% | |
| 36.5868% | |
| 14.2183% | |
| 15.5498% | |
| -151.4418% | |
| -273.4446% | |
| -234.386% | |
| -467.9685% | |
| -17.7828% | |
| 4.5204% | |
| 15.1154% | |
| 50.9577% | |
| -8.4057% | |
| 8.6312% | |
| 36.7702% | |
| -22.0172% | |
| -27.4458% | |
| -47.1367% | |
| -59.3398% | |
| -4.2085% | |
| 32.6074% |